Denise P, Bocca M L
Service des Explorations Fonctionnelles Neurologiques, CHU Côte de Nacre, 14033 Cedex, Caen, France.
Eur Neuropsychopharmacol. 2003 Mar;13(2):111-5. doi: 10.1016/s0924-977x(02)00153-0.
The effects of a single dose of zolpidem (10 mg), zopiclone (7.5 mg) and flunitrazepam (1 mg) on motor activity the following 3 nights were compared to those of a placebo in a double-blind, crossover study. Thirty-three healthy subjects received medication between 10.30 and 11.30 p.m. and were asked to rise between 7.30 and 8.30 a.m. During the night under treatment, flunitrazepam, zopiclone and zolpidem significantly reduced motor activity. Changes in motor activity are quantitatively compatible with the hypothesis of reduced light sleep and wakefulness after sleep onset. During the first or second post-drug night, for zolpidem and zopiclone the opposite effect was observed, i.e. increased activity compared with placebo. These modifications cannot be explained by modified sleep structure. This last result underlines our inadequate understanding of the underlying mechanisms of motor activity during sleep. However, being sensitive and easy to use, actigraphy is an ideal technique to assess the effect of hypnotics on large populations and for long duration studies.
在一项双盲交叉研究中,将单剂量唑吡坦(10毫克)、佐匹克隆(7.5毫克)和氟硝西泮(1毫克)在随后3晚对运动活动的影响与安慰剂进行了比较。33名健康受试者于晚上10:30至11:30服药,并被要求在早上7:30至8:30起床。在治疗期间的夜晚,氟硝西泮、佐匹克隆和唑吡坦显著降低了运动活动。运动活动的变化在数量上与睡眠开始后浅睡眠和清醒减少的假设相符。在用药后的第一个或第二个晚上,观察到唑吡坦和佐匹克隆有相反的效果,即与安慰剂相比活动增加。这些改变无法用睡眠结构的改变来解释。最后这个结果突出了我们对睡眠期间运动活动潜在机制的理解不足。然而,活动记录仪灵敏且易于使用,是评估催眠药对大量人群的影响以及进行长期研究的理想技术。